The new program is validated in a set of clinical pedigrees demonstrating its practical accuracy and relevance to the field. Collectively, the data are compelling and support the major conclusions of ...
Alert EMA OKs First Therapy for Non-Cystic Fibrosis Bronchiectasis Estimates suggest between 400,000 and three million people in Europe have NCFB.